Deaths due to tuberculosis among HIV-negative people in Europe (WHO region)
Europe (WHO region): Deaths due to tuberculosis among HIV-negative people was 1.6 in 2024. ◆ Volatile
Deaths due to tuberculosis among HIV-negative people in Europe (WHO region), 2000–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Europe (WHO region) recorded 1.6 for deaths due to tuberculosis among hiv-negative people in 2024. That is the lowest value across all 25 years on record.
The figure is down 5.9% on the previous year and down 56.8% over ten years.
Over the whole period, deaths due to tuberculosis among hiv-negative people in Europe (WHO region) peaked at 8.4 in 2000 and was at its lowest, 1.6, in 2024.
The series is highly variable year to year, so single readings are best treated with caution.
Deaths due to tuberculosis among HIV-negative people in Europe (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 8.4 | — |
| 2001 | 8.1 | -3.6% |
| 2002 | 8.1 | +0.0% |
| 2003 | 8.1 | +0.0% |
| 2004 | 7.7 | -4.9% |
| 2005 | 7.9 | +2.6% |
| 2006 | 7 | -11.4% |
| 2007 | 6.5 | -7.1% |
| 2008 | 6.3 | -3.1% |
| 2009 | 6 | -4.8% |
| 2010 | 5.4 | -10.0% |
| 2011 | 4.9 | -9.3% |
| 2012 | 4.5 | -8.2% |
| 2013 | 4.1 | -8.9% |
| 2014 | 3.7 | -9.8% |
| 2015 | 3.4 | -8.1% |
| 2016 | 3 | -11.8% |
| 2017 | 2.7 | -10.0% |
| 2018 | 2.5 | -7.4% |
| 2019 | 2.2 | -12.0% |
| 2020 | 2 | -9.1% |
| 2021 | 1.9 | -5.0% |
| 2022 | 1.8 | -5.3% |
| 2023 | 1.7 | -5.6% |
| 2024 | 1.6 | -5.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 7.41 | 6 | 8.4 | 10 |
| 2010s | 3.64 | 2.2 | 5.4 | 10 |
| 2020s | 1.8 | 1.6 | 2 | 5 |
Countries ranked near Europe (WHO region)
- 7 Myanmar 58 compare
- 8 Lesotho 57 compare
- 9 Namibia 54 compare
- 9 Congo, Democratic Republic of the 54 compare
- 11 Nepal 53 compare
- 12 Sierra Leone 48 compare
- 13 Central African Republic 47 compare
More health data for Europe (WHO region)
- Pertussis - number of reported cases, gaps filled 52,021 (2025)
- Measles - number of reported cases, gaps filled 38,686 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Diphtheria - number of reported cases, gaps filled 199 (2025)
- Total tetanus - number of reported cases, gaps filled 85 (2025)
- Number of infant deaths, annual growth rate -5.46 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -3.27 % change on previous year (2024)
- Number of under-five deaths, annual growth rate -8.58 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -74.39 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -82.58 % change on previous year (2025)
Frequently asked questions
- What is deaths due to tuberculosis among hiv-negative people in Europe (WHO region)?
- Deaths due to tuberculosis among hiv-negative people in Europe (WHO region) was 1.6 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest deaths due to tuberculosis among hiv-negative people recorded in Europe (WHO region)?
- The highest recorded value was 8.4 in 2000.
- What is the lowest deaths due to tuberculosis among hiv-negative people recorded in Europe (WHO region)?
- The lowest recorded value was 1.6 in 2024.
- How does Europe (WHO region) rank for deaths due to tuberculosis among hiv-negative people?
- Europe (WHO region) ranks 10th out of 11 groups with data for 2024.
- Is deaths due to tuberculosis among hiv-negative people rising or falling in Europe (WHO region)?
- Over the last ten years it is down 56.8%. The long-run trend across the full record is volatile.
- Where does this Europe (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Deaths due to tuberculosis among HIV-negative people (per 100 000 population). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).